If you look at the picture that I attached to my earlier post, that statement about the programs being still technically viable was included. I could have cut and paste a shorter version of it without that statement but I didn't. So I don't understand why you said that I decided to conveniently leave it out.
@tubbyguts 's analogy is spot on. Yes, those programs are technically still viable. However, for practical purposes, you can safely forget about them for the foreseeable future.
As others have said many times, the cancelled trial has been in Phase 3 since 2011. It was supposed to be MSB's leading candidate for commercialisation which would have provided MSB with much needed revenue. But it not only never finished, it was relegated to Tier 2, and then suspended.
Unfortunately, no amount of enthusiasm shown by Prof. Simmons can change this harsh reality.
If you are planning to attend this year's AGM, I strongly urge you to ask management about why before it was suspended, this program was relegated into tier 2 and never achieved its potential for early commercialisation.
MSB Price at posting:
$1.29 Sentiment: Sell Disclosure: Not Held
(20min delay)